Immunovant Inc
General ticker "IMVT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.1B
Immunovant Inc does not follow the US Stock Market performance with the rate: -19.2%.
Estimated limits based on current volatility of 2.4%: low 25.23$, high 26.46$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [17.44$, 44.17$]
- 2025-03-31 to 2026-03-31 estimated range: [10.73$, 29.50$]
Short-term IMVT quotes
Long-term IMVT plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $7.33MM | $0.00MM |
| Operating Expenses | $156.81MM | $218.28MM | $282.71MM |
| Operating Income | $-156.81MM | $-210.95MM | $-282.71MM |
| Non-Operating Income | $0.00MM | $0.00MM | $23.94MM |
| Interest Expense | $0.66MM | $12.48MM | $0.00MM |
| R&D Expense | $101.81MM | $160.26MM | $212.93MM |
| Income(Loss) | $-156.81MM | $-210.95MM | $-258.77MM |
| Taxes | $-0.08MM | $0.01MM | $0.57MM |
| Profit(Loss) | $-156.73MM | $-210.96MM | $-259.34MM |
| Stockholders Equity | $469.82MM | $362.49MM | $617.76MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $515.56MM | $405.84MM | $666.37MM |
| Operating Cash Flow | $-106.11MM | $-188.19MM | $-214.23MM |
| Capital expenditure | $0.25MM | $0.20MM | $0.36MM |
| Investing Cash Flow | $-0.25MM | $-0.20MM | $-0.36MM |
| Financing Cash Flow | $200.13MM | $70.89MM | $472.43MM |
| Earnings Per Share* | $-1.43 | $-1.71 | $-1.88 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.